Encompass Health dividend yield – Encompass Health Corporation Maintains Quarterly Dividend of $0.15 a Share, Payable Oct. 16 to Shareholders as of Oct. 2

July 29, 2023

☀️Trending News

Encompass Health ($NYSE:EHC) Corporation is a post-acute healthcare service provider, with operations managed through its inpatient rehabilitation segment. The company recently announced its quarterly dividend of $0.15 per share, payable on October 16 to shareholders who held their shares as of October 2. This dividend is a show of confidence in the future of the company, as they maintain the same level as the previous quarter. Investors are encouraged by Encompass Health Corporation’s commitment to financial stability and its dedication to returning value to shareholders through dividends. The dividend is just one of many recent positive developments for Encompass Health Corporation.

The company recently announced that it had entered into an agreement with Vesta Healthcare to acquire their suite of services, which will expand the scope of services that Encompass Health can provide. This move will further strengthen the company’s position as a leader in post-acute healthcare services. This dividend is payable on October 16 to those who held their shares as of October 2, so investors should take this opportunity to benefit from this dividend payment and the long-term prospects of Encompass Health Corporation.

Dividends – Encompass Health dividend yield

This marks the third consecutive year that the company has issued an annual dividend per share, with dividends of 0.73 USD in 2021, 0.86 USD in 2022, and 1.12 USD in 2023. The company also reported that its dividend yields for 2021 to 2023 are estimated at 1.36%, 1.68%, and 1.78%, respectively, yielding an average dividend yield of 1.61%.

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Encompass Health. More…

    Total Revenues Net Income Net Margin
    4.18k 270.4 6.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Encompass Health. More…

    Operations Investing Financing
    714.8 -607.9 -142.8
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Encompass Health. More…

    Total Assets Total Liabilities Book Value Per Share
    5.75k 3.78k 13.87
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Encompass Health are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    -3.6% -3.2% 15.0%
    FCF Margin ROE ROA
    3.6% 29.2% 6.8%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Market Price

    On the day of the announcement, Friday, Encompass Health‘s stock opened at $68.7 and closed at $66.6, indicating a 2.9% decrease from its last closing price of $68.6. Live Quote…

    Analysis

    Our analysis of ENCOMPASS HEALTH‘s financials has shown that the company is a low risk investment. Our risk rating process takes into consideration both financial and business aspects to determine the risk level of an investment. We have detected one risk warning in the company’s balance sheet, which is why we encourage our users to register with GoodWhale in order to learn more about this potential risk. We are confident in our ability to provide accurate insights into the financial health of companies, and we are sure that our analysis of ENCOMPASS HEALTH will be of great benefit to those considering investing in the company. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    There is fierce competition between Encompass Health Corp and its competitors: Community Health Systems Inc, Pennant Group Inc, Greenbrook TMS Inc. All four companies are leaders in the healthcare industry and are constantly striving to be the best.

    – Community Health Systems Inc ($NYSE:CYH)

    The company’s market capitalization is 311.19 million as of 2022. The company’s return on equity is -48.01%. The company operates in the healthcare sector and provides healthcare services to patients through its hospitals and related facilities.

    – Pennant Group Inc ($NASDAQ:PNTG)

    Pennant Group, Inc. provides healthcare services in the United States. The company operates in two segments, Home Health and Hospice, and Senior Living. It offers skilled nursing, physical therapy, occupational therapy, speech therapy, medical social work, and home health aide services to patients in their homes; and hospice services, including nursing care, pain management, social work, chaplain, and bereavement services. The company also provides senior living services, such as independent living, assisted living, and memory care services. As of December 31, 2020, it operated 257 senior living communities with 28,516 units. The company was formerly known as Curo Health Services, Inc. and changed its name to Pennant Group, Inc. in July 2018. Pennant Group, Inc. was founded in 2006 and is headquartered in Carrollton, Texas.

    – Greenbrook TMS Inc ($TSX:GTMS)

    Greenbrook TMS Inc is a healthcare company that provides treatment for depression and other mental disorders. The company has a market capitalization of 123.09M and a return on equity of -213.16%. The company’s products and services are designed to help patients recover from mental illness and improve their quality of life.

    Summary

    Encompass Health (ENC) has maintained its quarterly dividend at $0.15 per share, payable to shareholders as of October 2. This is a sign of the company’s financial strength and commitment to returning value to its shareholders. For investors considering Encompass Health, there are many positive signs to consider. The company has a strong balance sheet with substantial cash and cash equivalents, and total liabilities are modest relative to equity.

    Furthermore, Encompass Health is well-positioned to benefit from growing demand for post-acute healthcare services, as well as the aging population and expansion of insurance coverage in the US. Long-term investors looking for a solid dividend yield may find the current payout attractive.

    Recent Posts

    Leave a Comment